KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Gross Margin: 2018-2025

Historic Gross Margin for Dynavax Technologies (DVAX) over the last 8 years, with Sep 2025 value amounting to 84.82%.

  • Dynavax Technologies' Gross Margin rose 105.00% to 84.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 83.17%, marking a year-over-year increase of 32.00%. This contributed to the annual value of 82.17% for FY2024, which is 376.00% up from last year.
  • Per Dynavax Technologies' latest filing, its Gross Margin stood at 84.82% for Q3 2025, which was down 0.56% from 85.29% recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Gross Margin registered a high of 85.29% during Q2 2025, and its lowest value of 44.50% during Q3 2021.
  • Its 3-year average for Gross Margin is 80.80%, with a median of 81.38% in 2024.
  • Per our database at Business Quant, Dynavax Technologies' Gross Margin plummeted by 3,169bps in 2021 and then spiked by 2,637bps in 2023.
  • Dynavax Technologies' Gross Margin (Quarterly) stood at 62.06% in 2021, then plummeted by 406bps to 58.00% in 2022, then soared by 2,637bps to 84.37% in 2023, then slumped by 299bps to 81.38% in 2024, then skyrocketed by 105bps to 84.82% in 2025.
  • Its Gross Margin was 84.82% in Q3 2025, compared to 85.29% in Q2 2025 and 79.80% in Q1 2025.